Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Withdrawn before enrolling · Phase 4

Conditions studied: Opiate Addiction

In brief

This study is designed to determine the relative effectiveness of buprenorphine/naloxone (Suboxone) pharmacotherapy versus naltrexone pharmacotherapy for treatment retention, relapse prevention and opioid craving reduction among opioid-dependent adolescents and young adults. The investigators hypothesize that naltrexone treatment is as effective as buprenorphine/naloxone for these treatment outcomes.

Key facts

Study ID

NCT01015066

Run by

State University of New York at Buffalo

People needed

0

Starts

2009-11-01

Expected to finish

2014-06-01

Last updated by the study team

2014-06-10

Who can join

Age: 16 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical Diagnosis of Opiate Dependence
• Successful completion of detoxification
• can answer 9 out of 10 question correctly that tests understanding of the study

You may not qualify if…

• unable to pay for medication
• not living with a parent/guardian
• inability of patient and/or parent to give consent
• major co-occurring psychiatric disorder
• existing medical condition that would interfere with the treatment
• use of CNS depressants
• pregnancy

Where it is running

• UB Department of Family Medicine — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.